FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new chemical compounds of general formula I 
wherein LA, LB, LC, cycle A, cycle B, RA, RB, RC, RD, RE and RF have the values specified in the patent claim. The compounds of formula (I) are protein kinase inhibitors.
EFFECT: invention refers to pharmaceutical compositions containing the above compounds, as well as to using the above compounds for treating and/or preventing the diseases related to aberrant protein kinase activity, particularly oncological diseases.
10 cl, 14 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW METHOD OF SYNTHESIS OF TETRAHYDROPYRASIN[2,3-C]PYRIDAZINE DERIVATIVES | 2016 |
|
RU2631430C1 |
| SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITION ACTIVITY | 2000 |
|
RU2260008C2 |
| IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND USE THEREOF AS PROTEIN KINASE INHIBITOR | 2007 |
|
RU2487875C2 |
| PYRIDAZINONE MACROCYCLES AS IRAK-KINASE INHIBITORS AND USE THEREOF | 2016 |
|
RU2708066C2 |
| SUBSTITUTED PIRIDAZINE-CARBOXAMIDE COMPOUNDS AS KINASE-INHIBITING COMPOUNDS | 2009 |
|
RU2526618C2 |
| mTOR KINASE INHIBITORS FOR ONCOLOGICAL INDICATIONS AND DISEASES METABOLICALLY BOUND TO mTOR/PI3K/AKT | 2009 |
|
RU2546658C2 |
| CONDENSED AZA-HETEROCYCLIC AMIDE COMPOUND AND ITS USE | 2021 |
|
RU2811975C1 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
| NOVEL 3-PHENYLPROPIONIC ACID DERIVATIVES FOR TREATING DIABETES | 2005 |
|
RU2360906C2 |
